Rheumatoid arthritis: current pharmacologic treatment and anesthetic considerations.
A diagnosis of rheumatoid arthritis carries with it a lifelong progressive disease; however twenty percent of patients enjoy periods of partial to total remission. After remission, the disease will frequently plague previously unaffected joints. Life expectancy is reduced by an average of three to seven years. Complications of RA include vasculitis and amyloidosis affecting any vessel, including the aorta. Additionally, complications of therapy such as chronic NSAID use leading to GI bleeding and infections associated with long term steroid use, can add to the difficulties of the disease. The recent discovery and use of anticytokines and DMARDs has lead to greatly reduced symptomology associated with RA and greater patient comfort. Side effects of drugs should be well understood including the risk of bleeding from NSAIDs. Management and surgical intervention of problems that arise from this disease vary dramatically. The anesthesiologist must be aware of airway pathologies, pain management techniques, and available pharmacology parameters.
Tulane University School of Medicine, New Orleans, Louisiana, USA.
Deepa
D
Reddy
Landon W
LW
Trost
Travis
T
Lee
Amir R
AR
Baluch
Alan D
AD
Kaye
D000758:Anesthesia / Q000009:adverse effects* / Q000379:methods*; D000776:Anesthesiology / Q000379:methods*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000150:complications* / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans
D000893:Anti-Inflammatory Agents